Dr. Djamchid Lotfi
Claim this profileClinical Trial Network
Studies Parkinson's Disease
Studies Multiple Sclerosis
9 reported clinical trials
9 drugs studied
Area of expertise
1Parkinson's Disease
Stage I
Stage II
2Multiple Sclerosis
Affiliated Hospitals
Clinical Trials Djamchid Lotfi is currently running
Masupirdine
for Agitation in Alzheimer's Disease
This trial will test a medication called masupirdine, which participants will take regularly. It targets people with Alzheimer's disease who are experiencing agitation. The study aims to see if masupirdine can help reduce agitation and ensure it is safe and well-tolerated. Masupirdine has been previously evaluated in patients with moderate Alzheimer's disease and was found to be generally safe and well-tolerated.
Recruiting1 award Phase 32 criteria
Mevidalen
for Alzheimer's Disease
The main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer Disease (AD) dementia. This is done by looking at participants: thinking and memory (cognition), everyday activities and sleep, AD symptoms, physical activity, irritability or anxiety. The study is expected to last approximately 26 weeks and may include up to 14 visits.
Recruiting0 awards Phase 21 criteria
More about Djamchid Lotfi
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Djamchid Lotfi has experience with
- Placebo
- HB-adMSCs
- Allogeneic HB-adMSCs
- Masupirdine
- Pirtobrutinib
- Mevidalen
Breakdown of trials Djamchid Lotfi has run
Parkinson's Disease
Multiple Sclerosis
Alzheimer's Dementia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Djamchid Lotfi specialize in?
Djamchid Lotfi focuses on Parkinson's Disease and Multiple Sclerosis. In particular, much of their work with Parkinson's Disease has involved Stage I patients, or patients who are Stage II.
Is Djamchid Lotfi currently recruiting for clinical trials?
Yes, Djamchid Lotfi is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Djamchid Lotfi has studied deeply?
Yes, Djamchid Lotfi has studied treatments such as Placebo, HB-adMSCs, Allogeneic HB-adMSCs.
What is the best way to schedule an appointment with Djamchid Lotfi?
Apply for one of the trials that Djamchid Lotfi is conducting.
What is the office address of Djamchid Lotfi?
The office of Djamchid Lotfi is located at: Clinical Trial Network, Houston, Texas 77074 United States. This is the address for their practice at the Clinical Trial Network.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.